OUR PIPELINE

BioInvent has two active projects in clinical development.

 


In addition, BioInvent has a number of research stage projects that we consider promising; especially in the field of immuno-oncology.

READ MORE

Business Focus

BioInvent is generating value for shareholders by employing its antibody and cancer biology expertise to identify antibodies with novel mechanisms-of-action and novel oncology targets. The Company employs this approach to generate therapeutic immuno-modulating antibodies that can be developed for a broad range of cancer indications. The Company plans to bring these antibodies to the clinic through its own resources and together with partners.

READ MORE

Press Releases

MEET US

1-5 Apr, 2017, AACR, Washington D.C., USA
6 Apr, 2017, Financial Meetings Øresund, Lund, Sweden
11 Apr, 2017, 2017 Cancer Advance, Boston, USA
24-25 Apr, 2017, 10th Annual Proteins and Antibodies Congress, London, UK

SEK